supplementary new drug application (sNDA)
GSK’s Nucala Gets Closer to Approval for Severe Asthma in Japan
Anika Sharma
GSK has unveiled a ray of hope for millions of Japanese individuals grappling with the debilitating burden of chronic rhinosinusitis ...
